Ironwood Pharmaceuticals (IRWD) Enterprise Value (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Enterprise Value of -$220.5 million for Q1 2026, down 2.33% sequentially from -$215.5 million in Q4 2025, and down 103.23% YoY from $6.8 billion in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Enterprise Value (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Enterprise Value for 17 years, with the latest figure at -$220.5 million in Q1 2026.
- Quarterly Enterprise Value fell 103.23% year-over-year to -$220.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$220.5 million (down 103.23% YoY) and the FY2025 annual result came in at -$215.5 million, down 143.29% from the prior year.
- Enterprise Value retreated to -$220.5 million in Q1 2026 per IRWD's latest filing, from -$215.5 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$88.2 million in Q3 2024 and troughed at -$741.6 million in Q1 2023.
- A 5-year average of -$272.9 million and a median of -$140.4 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value surged 85.98% in 2023, then slumped 143.29% in 2025.
- Over 5 years, Enterprise Value stood at -$657.5 million in 2022, then surged by 85.98% to -$92.2 million in 2023, then rose by 3.9% to -$88.6 million in 2024, then sank by 143.29% to -$215.5 million in 2025, then fell by 2.33% to -$220.5 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$220.5 million, -$215.5 million, and -$140.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | -164.00 Mn |
| 10 | Ironwood Pharmaceuticals | 678.83 Mn | 599.70 Mn | - | -79.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -79.13 Mn |
| Mar 31, 2026 | -220.47 Mn |
| Dec 31, 2025 | -215.46 Mn |
| Sep 30, 2025 | -140.41 Mn |
| Jun 30, 2025 | -92.85 Mn |
| Mar 31, 2025 | -108.48 Mn |
| Dec 31, 2024 | -88.56 Mn |
| Sep 30, 2024 | -88.21 Mn |
| Jun 30, 2024 | -105.52 Mn |
| Mar 31, 2024 | -121.54 Mn |
| Dec 31, 2023 | -92.15 Mn |
| Sep 30, 2023 | -113.42 Mn |
| Jun 30, 2023 | -177.18 Mn |
| Mar 31, 2023 | -741.59 Mn |
| Dec 31, 2022 | -657.45 Mn |
| Sep 30, 2022 | -575.44 Mn |
| Jun 30, 2022 | -505.62 Mn |
| Mar 31, 2022 | -594.80 Mn |
| Dec 31, 2021 | -621.38 Mn |
| Sep 30, 2021 | -575.53 Mn |